Loading...
The Effectiveness of Trastuzumab Combined with Sequential Chemotherapy for Metastatic Gastric Carcinoma with Overexpression of HER2
Metastatic gastric carcinoma is a mortal disease with a median survival of barely 10 months. An approximate 20% of the cases overexpress HER2, and among them, the combination of chemotherapy with trastuzumab is actually the first-line palliative treatment. However, after progression, sequential stra...
Saved in:
| Published in: | Case Rep Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
S. Karger AG
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5567011/ https://ncbi.nlm.nih.gov/pubmed/28868025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000478003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|